# Study of Fruquintinib in Patients With Metastatic Colorectal Cancer

> **NCT02196688** · PHASE2 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 71 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** fruquintinib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02196688
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-11
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2020-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196688, "Study of Fruquintinib in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02196688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*